June 19-21
Boston, USA

Register by Friday, May 11 to Save up to $500 

 

Combination product has been trending in the pharma market, and drug-device combo market is expected to reach $177.7 billion by 2024*.

The regulatory approval pathway for combo product isn’t the easiest, and maintaining market positions in such fierce competition is even more challenging for drug and device developers. A refined and innovative lifecycle management strategy plays a pivotal role to maximizing product longevity and commercial advantage.

Building on the success of PFS & Injectables Summit, the Combination Products Lifecycle Management Summit will create a unique platform for the commercial, quality and regulatory leaders in this segment.

Join this 3-day peer-led summit to stay abreast on market trends and innovations!

Download the full event guide to view the full agenda.

*Source: Grand View Research

“Although you have been in this industry for decades, you will still learn a lot from this conference!” 

Shire, Hanson Wade Event Past Attendee

"I found this conference enjoyable and learned a lot. Several of the speakers shared their own experiences and lessons learned, which I will be able to directly apply in my job"

Pfizer, Hanson Wade Event Past Attendee


Media Partner